LigaChem Biosciences Inc. (KOSDAQ:141080)
South Korea flag South Korea · Delayed Price · Currency is KRW
104,300
-9,000 (-7.94%)
Jul 14, 2026, 3:30 PM KST

LigaChem Biosciences Revenue

LigaChem Biosciences had revenue of 35.89B KRW in the quarter ending March 31, 2026, a decrease of -30.42%. This brings the company's revenue in the last twelve months to 125.87B, down -14.04% year-over-year. In the year 2025, LigaChem Biosciences had annual revenue of 141.55B with 12.43% growth.

Revenue (ttm)
125.87B
Revenue Growth
-14.04%
P/S Ratio
30.54
Revenue / Employee
662.45M
Employees
190
Market Cap
3.84T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025141.55B15.65B12.43%
Dec 31, 2024125.90B91.75B268.71%
Dec 31, 202334.15B733.60M2.20%
Dec 31, 202233.41B1.26B3.90%
Dec 31, 202132.16B-25.34B-44.07%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Epis Holdings1.51T
SK Biopharmaceuticals790.25B
SK bioscience665.42B
Hugel451.93B
ALTEOGEN203.76B
HLB Co., Ltd.85.20B
OliX Pharmaceuticals17.26B
Voronoi7.51B
Revenue Rankings